From Vial
to Receptor

Pick up a vial of any compounded peptide. Read the label. The dose is in micrograms. The volume is in milliliters. The instruction is to inject a tiny amount under the skin. What follows that injection, in the next thirty seconds and the next thirty minutes, is one of the most precise sequences of biology your body performs.

This is the story of one molecule. It starts in the syringe and ends at a receptor on a cell that was waiting for exactly this signal.

The injection

The needle goes through skin into the layer of fatty tissue underneath, the subcutaneous space. The plunger pushes a small bolus of fluid into a region rich with two kinds of vessels: capillaries, which are tiny blood vessels with leaky walls, and lymphatic vessels, which collect fluid from tissues and return it to the circulation. Smaller peptides enter the capillaries directly. Larger peptides travel through the lymphatic system first.

Either way, within minutes, the molecule is in your bloodstream.

The bloodstream

In the blood, your peptide is one molecule among many. Cardiac output moves about five liters of blood every minute, which means the entire blood volume passes through the heart roughly once a minute. From the heart, the blood is sent to the lungs, then back to the heart, then out through the arteries to every tissue. Your peptide rides along.

How long it survives depends on its chemistry. Native peptides like your own GLP-1 are degraded within minutes by enzymes called peptidases. Modified peptides, like semaglutide, attach a fatty acid that lets them bind to albumin, the most abundant protein in your blood. Bound to albumin, semaglutide can survive in circulation for about a week. The body's clearance machinery cannot reach it as easily.

The capillary, then the cell surface

Eventually your molecule reaches the target tissue. Capillaries throughout the body are lined with endothelial cells, and the walls of those capillaries vary in how permeable they are. In organs like the liver, the gaps are wide. In organs like the brain, the gaps are tight. The peptide diffuses through whichever pathway its receptor demands.

Outside the capillary now, in the interstitial fluid surrounding cells, the peptide encounters the cell surface. It is looking for one specific feature: a receptor that fits its shape. Receptors are proteins embedded in the cell membrane. Each receptor has a binding pocket designed for a specific signal. The largest single family of receptors, called G protein-coupled receptors or GPCRs, contains around eight hundred members in the human genome. Most peptide hormones bind to receptors in this family.

The lock-on

Binding is fast. The peptide approaches the receptor at thermal speed, finds the right shape, and locks into place in milliseconds. The receptor changes shape in response. This is not a static lock-and-key. It is closer to a handshake: both the peptide and the receptor adjust to fit each other better. Biochemists call this induced fit, and it has been the working model of receptor binding for more than half a century.

The shape change in the receptor is what makes everything else possible. The receptor sits across the cell membrane, with one part outside the cell and another part inside. When the outside part changes shape, the inside part changes shape too. The cell now knows that something has bound to its surface. The signal has crossed.

The cascade

Most peptide receptors belong to the GPCR family. When the receptor changes shape, it activates an attached protein on the inside of the cell, called a G protein. The G protein activates an enzyme. The enzyme produces a small molecule called a second messenger, often cyclic AMP. The second messenger activates other enzymes. Those enzymes alter the activity of dozens of proteins in the cell.

This is amplification. One peptide molecule, binding once, triggers a chain of events that multiplies the signal a hundredfold or more. Within seconds, the cell has changed what it is doing. Insulin is released from a beta cell. Hunger fades from a hypothalamic neuron. A growth signal is broadcast to neighboring cells. A blood vessel relaxes.

The end of the signal

The peptide does not stay bound forever. It eventually dissociates from the receptor, or the receptor pulls the entire complex inside the cell, where the peptide is broken down by intracellular enzymes. The receptor either recycles back to the membrane surface or is itself degraded. The blood concentration of free peptide falls. Other receptors stop being activated. The signal fades.

A short-acting peptide like native GLP-1 has a useful biological window of a few minutes. A modified peptide like semaglutide has a window of about a week. The chemistry of each peptide is engineered to land in a specific window for a specific therapeutic purpose.

Why this matters

Peptide therapy is precision medicine in the most literal sense. The molecule is engineered to bind a specific receptor at a specific concentration for a specific duration. Every part of the journey from skin to receptor is governed by physics and chemistry that have been studied for more than a hundred years. None of it is guesswork.

At pru, the prescription you receive has been written for the receptor you need to reach. The molecule has been compounded to a tested standard. The dose has been chosen to land in the biological window where it does what it is supposed to do. The vial in your refrigerator is a delivery system for a conversation your cells already know how to have.